Gene · 54583
Papers3,727
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 3,727
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Individual variations and sex differences in hemodynamics and percutaneous arterial oxygen saturation (SpO2) in Tibetan highlanders of Tsarang in the Mustang district of Nepal. | J Physiol Anthropol | 2022 | 35292118 | PubTator, text mining | PubMed |
| Clinical Potential of Hypoxia Inducible Factors Prolyl Hydroxylase Inhibitors in Treating Nonanemic Diseases. | Front Pharmacol | 2022 | 35281917 | PubTator, text mining | PubMed |
| OpenCell: Endogenous tagging for the cartography of human cellular organization. | Science | 2022 | 35271311 | PubTator, text mining | PubMed |
| Dysregulation of Oxygen Sensing/Response Pathways in Pregnancies Complicated by Idiopathic Intrauterine Growth Restriction and Early-Onset Preeclampsia. | Int J Mol Sci | 2022 | 35269911 | PubTator, text mining | PubMed |
| Current Development, Obstacle and Futural Direction of Induced Pluripotent Stem Cell and Mesenchymal Stem Cell Treatment in Degenerative Retinal Disease. | Int J Mol Sci | 2022 | 35269671 | PubTator, text mining | PubMed |
| Hypoxia-Inducible Factors and Burn-Associated Acute Kidney Injury-A New Paradigm? | Int J Mol Sci | 2022 | 35269613 | PubTator, text mining | PubMed |
| Signal Transduction during Metabolic and Inflammatory Reprogramming in Pulmonary Vascular Remodeling. | Int J Mol Sci | 2022 | 35269553 | PubTator, text mining | PubMed |
| Sporoderm-Broken Spores of Ganoderma lucidum Sensitizes Ovarian Cancer to Cisplatin by ROS/ERK Signaling and Attenuates Chemotherapy-Related Toxicity. | Front Pharmacol | 2022 | 35264959 | PubTator, text mining | PubMed |
| Missense Variants Reveal Functional Insights Into the Human ARID Family of Gene Regulators. | J Mol Biol | 2022 | 35257783 | PubTator, text mining | PubMed |
| Dysregulation of the Nitric Oxide/Dimethylarginine Pathway in Hypoxic Pulmonary Vasoconstriction-Molecular Mechanisms and Clinical Significance. | Front Med (Lausanne) | 2022 | 35252268 | PubTator, text mining | PubMed |
| Adaptation of the Oxygen Sensing System during Lung Development. | Oxid Med Cell Longev | 2022 | 35242281 | PubTator, text mining | PubMed |
| Deferoxamine Inhibits Acute Lymphoblastic Leukemia Progression through Repression of ROS/HIF-1α, Wnt/β-Catenin, and p38MAPK/ERK Pathways. | J Oncol | 2022 | 35237325 | PubTator, text mining | PubMed |
| A PRC2-Kdm5b axis sustains tumorigenicity of acute myeloid leukemia. | Proc Natl Acad Sci U S A | 2022 | 35217626 | PubTator, text mining | PubMed |
| Role of mitochondrial reactive oxygen species in homeostasis regulation. | Redox Rep | 2022 | 35213291 | PubTator, text mining | PubMed |
| The Impact of Intermittent Hypoxemia on Left Atrial Remodeling in Patients with Obstructive Sleep Apnea Syndrome. | Life (Basel) | 2022 | 35207436 | PubTator, text mining | PubMed |
| Pheochromocytomas and Abdominal Paragangliomas: A Practical Guidance. | Cancers (Basel) | 2022 | 35205664 | PubTator, text mining | PubMed |
| The Role of VHL in the Development of von Hippel-Lindau Disease and Erythrocytosis. | Genes (Basel) | 2022 | 35205407 | PubTator, text mining | PubMed |
| Genomic Diversity Profiling and Breed-Specific Evolutionary Signatures of Selection in Arunachali Yak. | Genes (Basel) | 2022 | 35205299 | PubTator, text mining | PubMed |
| Structure-Activity Relationships and Transcriptomic Analysis of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors. | Antioxidants (Basel) | 2022 | 35204103 | PubTator, text mining | PubMed |
| Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia. | Curr Oncol | 2022 | 35200567 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54583/papers?page=47